TGFB1 and Peritoneal Fibrosis: The accuracy of the predictions was verified through in vivo testing utilizing a mouse model of peritoneal fibrosis and in vitro experiments involving the treatment of the cultured human mesothelial cell line (Met5-A cells) with transforming growth factor-β1 (TGF-β1) or high glucose.